Mothers . | Azithromycin . | Placebo . |
---|---|---|
n = 244 . | n = 256 . | |
Country, n (%) | ||
The Gambia | 122 (50.0) | 128 (50.0) |
Burkina Faso | 122 (50.0) | 128 (50.0) |
Age,a median (IQR), y | 26.0 (21.0–31.0) | 26.0 (21.0–30.0) |
Ethnicity, n (%) | ||
Mandinka | 47 (19.3) | 50 (19.5) |
Wollof | 20 (8.2) | 20 (7.8) |
Jola | 14 (5.7) | 16 (6.3) |
Fula | 21 (8.6) | 19 (7.4) |
Mossi | 115 (47.1) | 120 (46.9) |
Gourounsi | 5 (2.0) | 7 (2.7) |
Peulh | 2 (0.8) | 1 (0.4) |
Other | 20 (8.2) | 23 (9.0) |
Season of delivery,b n (%) | ||
Dry (Nov–May) | 137 (56.1) | 134 (52.3) |
Wet (June–Oct) | 106 (43.4) | 120 (46.9) |
Mode of delivery, n (%) | ||
Vaginal | 238 (97.5) | 251 (98.0) |
Cesarean | 6 (2.5) | 5 (2.0) |
Multiple pregnancy, n (%) | 3 (1.2) | 2 (0.8) |
Newborns | n = 244 | n = 256 |
Sex, n (%) | ||
Female | 120 (49.2) | 121 (47.3) |
Male | 124 (50.8) | 135 (52.7) |
Birth weight,c median (IQR), kg | 3.0 (2.8–3.3) | 3 (2.8–3.35) |
Mothers . | Azithromycin . | Placebo . |
---|---|---|
n = 244 . | n = 256 . | |
Country, n (%) | ||
The Gambia | 122 (50.0) | 128 (50.0) |
Burkina Faso | 122 (50.0) | 128 (50.0) |
Age,a median (IQR), y | 26.0 (21.0–31.0) | 26.0 (21.0–30.0) |
Ethnicity, n (%) | ||
Mandinka | 47 (19.3) | 50 (19.5) |
Wollof | 20 (8.2) | 20 (7.8) |
Jola | 14 (5.7) | 16 (6.3) |
Fula | 21 (8.6) | 19 (7.4) |
Mossi | 115 (47.1) | 120 (46.9) |
Gourounsi | 5 (2.0) | 7 (2.7) |
Peulh | 2 (0.8) | 1 (0.4) |
Other | 20 (8.2) | 23 (9.0) |
Season of delivery,b n (%) | ||
Dry (Nov–May) | 137 (56.1) | 134 (52.3) |
Wet (June–Oct) | 106 (43.4) | 120 (46.9) |
Mode of delivery, n (%) | ||
Vaginal | 238 (97.5) | 251 (98.0) |
Cesarean | 6 (2.5) | 5 (2.0) |
Multiple pregnancy, n (%) | 3 (1.2) | 2 (0.8) |
Newborns | n = 244 | n = 256 |
Sex, n (%) | ||
Female | 120 (49.2) | 121 (47.3) |
Male | 124 (50.8) | 135 (52.7) |
Birth weight,c median (IQR), kg | 3.0 (2.8–3.3) | 3 (2.8–3.35) |
Abbreviation: IQR, interquartile range.
aAge missing for n = 52.
bSeason of delivery missing for n = 3.
cBirth weight missing for n = 1.
Mothers . | Azithromycin . | Placebo . |
---|---|---|
n = 244 . | n = 256 . | |
Country, n (%) | ||
The Gambia | 122 (50.0) | 128 (50.0) |
Burkina Faso | 122 (50.0) | 128 (50.0) |
Age,a median (IQR), y | 26.0 (21.0–31.0) | 26.0 (21.0–30.0) |
Ethnicity, n (%) | ||
Mandinka | 47 (19.3) | 50 (19.5) |
Wollof | 20 (8.2) | 20 (7.8) |
Jola | 14 (5.7) | 16 (6.3) |
Fula | 21 (8.6) | 19 (7.4) |
Mossi | 115 (47.1) | 120 (46.9) |
Gourounsi | 5 (2.0) | 7 (2.7) |
Peulh | 2 (0.8) | 1 (0.4) |
Other | 20 (8.2) | 23 (9.0) |
Season of delivery,b n (%) | ||
Dry (Nov–May) | 137 (56.1) | 134 (52.3) |
Wet (June–Oct) | 106 (43.4) | 120 (46.9) |
Mode of delivery, n (%) | ||
Vaginal | 238 (97.5) | 251 (98.0) |
Cesarean | 6 (2.5) | 5 (2.0) |
Multiple pregnancy, n (%) | 3 (1.2) | 2 (0.8) |
Newborns | n = 244 | n = 256 |
Sex, n (%) | ||
Female | 120 (49.2) | 121 (47.3) |
Male | 124 (50.8) | 135 (52.7) |
Birth weight,c median (IQR), kg | 3.0 (2.8–3.3) | 3 (2.8–3.35) |
Mothers . | Azithromycin . | Placebo . |
---|---|---|
n = 244 . | n = 256 . | |
Country, n (%) | ||
The Gambia | 122 (50.0) | 128 (50.0) |
Burkina Faso | 122 (50.0) | 128 (50.0) |
Age,a median (IQR), y | 26.0 (21.0–31.0) | 26.0 (21.0–30.0) |
Ethnicity, n (%) | ||
Mandinka | 47 (19.3) | 50 (19.5) |
Wollof | 20 (8.2) | 20 (7.8) |
Jola | 14 (5.7) | 16 (6.3) |
Fula | 21 (8.6) | 19 (7.4) |
Mossi | 115 (47.1) | 120 (46.9) |
Gourounsi | 5 (2.0) | 7 (2.7) |
Peulh | 2 (0.8) | 1 (0.4) |
Other | 20 (8.2) | 23 (9.0) |
Season of delivery,b n (%) | ||
Dry (Nov–May) | 137 (56.1) | 134 (52.3) |
Wet (June–Oct) | 106 (43.4) | 120 (46.9) |
Mode of delivery, n (%) | ||
Vaginal | 238 (97.5) | 251 (98.0) |
Cesarean | 6 (2.5) | 5 (2.0) |
Multiple pregnancy, n (%) | 3 (1.2) | 2 (0.8) |
Newborns | n = 244 | n = 256 |
Sex, n (%) | ||
Female | 120 (49.2) | 121 (47.3) |
Male | 124 (50.8) | 135 (52.7) |
Birth weight,c median (IQR), kg | 3.0 (2.8–3.3) | 3 (2.8–3.35) |
Abbreviation: IQR, interquartile range.
aAge missing for n = 52.
bSeason of delivery missing for n = 3.
cBirth weight missing for n = 1.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.